Sensorium Therapeutics
Komla M. Gnona has a diverse work experience. In 2013, they began as a Peer Tutor at Columbus State Community College. In 2015, they were a Conservation Intern at American Conservation Experience. From 2016 to 2019, they were a Project Management and Leadership at The Ohio State University, where they developed research initiatives and protocols, identified genetic biomarkers of lung disease, and maintained professional relationships with thought leaders and physicians. In 2019, they became an Intellectual Property Intern at Nationwide Children's Hospital, developing and delivering medically meaningful and commercially useful presentations. Currently, they are a Scientist at Sensorium Therapeutics.
Komla M. Gnona attended The Ohio State University from 2011 to 2022, during which time they obtained a Bachelor of Science (B.S.) in Mathematics in 2015, a Master's Degree in Biophysics in 2020, and a Doctor of Philosophy - PhD in Biophysics in 2022. Prior to attending The Ohio State University, they obtained an Associate's degree in Mathematics from the Community College of Philadelphia in 2011. Additionally, they attended Kouvahey, though no further information is available.
Sensorium Therapeutics
Founded by world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University, Sensorium Therapeutics is a biotechnology company leveraging cutting-edge chemistry, neuroscience, and machine learning to develop nature-derived psychoactive medicines for mental health. Inspired by the real-world human benefits of plants and fungi, Sensorium’s groundbreaking Biodynamic Discovery Platform leverages cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can deliver transformational benefits to patients around the world.